Aya Katayama

Title: Aya Katayama: Innovator in Tumor Analysis

Introduction

Aya Katayama is a prominent inventor based in Kakogawa, Japan. She has made significant contributions to the field of medical technology, particularly in the analysis of malignant tumors. With a total of 2 patents to her name, her work is paving the way for advancements in cancer diagnostics.

Latest Patents

One of her latest patents is a "Method for Judging Feature of Malignant Tumor." This innovative method involves several steps, including obtaining parameters based on the activity and expression levels of cyclin-dependent kinases (CDKs) in tumor cells. The process includes comparing these parameters against threshold values to determine the characteristics of the malignant tumor.

Another notable patent is the "Reagent Kit for Determining Characteristic of Tissue." This kit is designed for measuring the expression levels and activity values of CDKs in tissue samples obtained from patients. It includes specific reagents stored under controlled conditions to ensure accurate results.

Career Highlights

Aya Katayama is currently employed at Sysmex Corporation, where she continues to develop her groundbreaking technologies. Her work is instrumental in enhancing the understanding and treatment of cancer.

Collaborations

She collaborates with esteemed colleagues, including Hideki Ishihara and Yuko Kawasaki, who contribute to her research and development efforts.

Conclusion

Aya Katayama's innovative work in tumor analysis is making a significant impact in the medical field. Her patents reflect her dedication to improving cancer diagnostics and treatment options.